Actively building life science companies

5AM Ventures is a leading venture capital firm focused on building next-generation life science companies capable of delivering outstanding returns to our investors.

Scroll to experience 5AM Ventures

Supporting companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science.

Read Me

fda grants qidp and fast track designations to cidara therapeutics’ rezafungin prophylaxis development program
Read Me

nodthera announces the appointment of adam keeney phd as president and chief executive officer
Read Me

kinestral’s halio smart-tinting glass selected for integration into katerra smart homes & buildings
Read Me

cidara therapeutics appoints david gollaher, ph.d., to board of directors
Read Me

biodesy announces new ceo and $20 million series c financing to accelerate expansion into biotherapeutics discovery and development market

Pushing the healthcare industry forward

$ 1 B

UNDER MANAGEMENT

We’re a life science venture capital firm founded in 2002 and currently investing $285M from our fifth fund.
69

PORTFOLIO COMPANIES

Our focus is biopharmaceuticals, drug delivery technologies and life science instruments.
30

ONGOING CLINICAL TRIALS

Our portfolio companies currently have over 2000 patients enrolled across 250 test sites in ongoing clinical trials.

San Francisco, CA

Boston, MA